Protein Arginine Methyltransferases 5 (PRMT5) affect Multiple Stages of Autophagy and Modulate Autophagy-related

Jing Kong1, Zhe Wang1, Yong Zhang2

  • 1Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, P.R. China.

Current Cancer Drug Targets
|September 26, 2022
PubMed
Abstract

Insights

Protein arginine methyltransferase 5 (PRMT5) promotes breast cancer cell proliferation and enhances autophagy. Targeting PRMT5 may offer new therapeutic strategies for breast cancer treatment.

Area of Science:

  • Cellular Biology
  • Oncology
  • Molecular Mechanisms

Background:

  • Autophagy disorders are implicated in human cancers, but their precise mechanisms are not fully understood.
  • Investigating the role of specific molecules in cancer-related autophagy is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the regulatory function of Protein Arginine Methyltransferase 5 (PRMT5) in the autophagy process within breast cancer cells.
  • To determine if PRMT5 influences breast cancer cell proliferation and autophagy.

Main Methods:

  • Utilized human breast adenocarcinoma cell lines (MDA-MB-231, MCF7).
  • Manipulated PRMT5 expression via overexpression and down-regulation plasmids.
  • Assessed cell proliferation using MTT assays.
  • Analyzed autophagy-associated molecule expression via Western blotting and immunofluorescence (GFP-LC3).

Main Results:

  • PRMT5 expression decreased sensitivity to rapamycin and nutrient deprivation.
  • PRMT5 acts as an oncogene, promoting cell proliferation, migration, and stemness.
  • Elevated PRMT5 expression enhanced autophagic activity induced by EBSS and rapamycin.
  • PRMT5 was essential for enhancing stress-induced autophagy and regulating autophagy-related gene expression (e.g., Atg5, ULK1).

Conclusions:

  • PRMT5 plays a significant role in regulating autophagy at multiple stages, impacting tumorigenesis.
  • Autophagy-related PRMT5 presents a potential therapeutic target for cancer interventions.
  • This research offers novel insights for breast cancer treatment and target selection.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K